As of 2025-09-15, the EV/EBITDA ratio of agilon health Inc (AGL) is -1.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 306.96 mil USD. AGL's TTM EBITDA according to its financial statements is -308.37 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 12.4x | 11.8x |
| Forward P/E multiples | 11.3x - 12.5x | 12.2x |
| Fair Price | (8.09) - (8.91) | (8.56) |
| Upside | -856.4% - -932.9% | -900.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -1.00 |
| 2025-09-11 | -1.01 |
| 2025-09-10 | -1.08 |
| 2025-09-09 | -1.10 |
| 2025-09-08 | -1.25 |
| 2025-09-05 | -1.17 |
| 2025-09-04 | -1.18 |
| 2025-09-03 | -1.17 |
| 2025-09-02 | -1.26 |
| 2025-08-29 | -1.28 |
| 2025-08-28 | -1.26 |
| 2025-08-27 | -1.30 |
| 2025-08-26 | -1.21 |
| 2025-08-25 | -1.41 |
| 2025-08-22 | -1.34 |
| 2025-08-21 | -1.21 |
| 2025-08-20 | -1.18 |
| 2025-08-19 | -1.24 |
| 2025-08-18 | -1.21 |
| 2025-08-15 | -1.05 |
| 2025-08-14 | -0.98 |
| 2025-08-13 | -0.97 |
| 2025-08-12 | -0.76 |
| 2025-08-11 | -0.72 |
| 2025-08-08 | -0.73 |
| 2025-08-07 | -0.73 |
| 2025-08-06 | -0.75 |
| 2025-08-05 | -0.74 |
| 2025-08-04 | -2.00 |
| 2025-08-01 | -1.84 |
| 2025-07-31 | -1.96 |
| 2025-07-30 | -2.12 |
| 2025-07-29 | -2.15 |
| 2025-07-28 | -2.23 |
| 2025-07-25 | -2.33 |
| 2025-07-24 | -2.34 |
| 2025-07-23 | -2.63 |
| 2025-07-22 | -2.49 |
| 2025-07-21 | -2.43 |
| 2025-07-18 | -2.41 |
| 2025-07-17 | -2.47 |
| 2025-07-16 | -2.46 |
| 2025-07-15 | -2.51 |
| 2025-07-14 | -2.58 |
| 2025-07-11 | -2.55 |
| 2025-07-10 | -2.66 |
| 2025-07-09 | -2.63 |
| 2025-07-08 | -2.77 |
| 2025-07-07 | -2.69 |
| 2025-07-03 | -2.82 |